NCT07185009 - A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis | Biotech Hunter

Enrollment

671

Participants

Timeline

Start Date

January 7, 2026

Primary Completion Date

September 21, 2028

Study Completion Date

April 28, 2033

Conditions

Ulcerative Colitis

Interventions

DRUG

Duvakitug

Pharmaceutical form: Injection solution Route of administration: SC injection

DRUG

Placebo

Pharmaceutical form:Injection solution-Route of administration:SC injection

Trial Locations (2)

RECRUITING

Precision Clinical Research, Coral Springs

RECRUITING

Correa Research Center, Miami